methylcyanocarbamate dimer has been researched along with 3-hydroxyisovalerylcarnitine in 1 studies
| Studies (methylcyanocarbamate dimer) | Trials (methylcyanocarbamate dimer) | Recent Studies (post-2010) (methylcyanocarbamate dimer) | Studies (3-hydroxyisovalerylcarnitine) | Trials (3-hydroxyisovalerylcarnitine) | Recent Studies (post-2010) (3-hydroxyisovalerylcarnitine) |
|---|---|---|---|---|---|
| 8 | 0 | 6 | 26 | 2 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Gu, X; Han, L; Liang, L; Lu, D; Qiu, W; Xu, F; Yang, Y; Zhang, H; Zhang, K | 1 |
1 other study(ies) available for methylcyanocarbamate dimer and 3-hydroxyisovalerylcarnitine
| Article | Year |
|---|---|
[Analysis of disease spectrum for abnormal 3-hydroxyisovalerylcarnitine metabolism identified through newborn screening and clinical diagnosis].
Topics: China; Humans; Infant, Newborn; Neonatal Screening; Retrospective Studies; Tandem Mass Spectrometry | 2023 |